Clinical Trial

Androgen Effects on the Reproductive Neuroendocrine Axis, 2025 Version

Recruiting Phase 4
View on ClinicalTrials.gov →
Summary
This research study investigates whether male-level exogenous androgens inhibit the reproductive neuroendocrine axis in otherwise healthy (non-PCOS) females.
Protocol Amendment History 3 amendments
This ClinicalTrials.gov record has been amended 3 times since 2025-07-22; most recent amendment 2026-01-13.
Status change: Not Yet Recruiting → Recruiting 2025-09-29
Trial Details
NCT Number NCT07092527
Lead Sponsor University of California, San Diego
Collaborators: National Institutes of Health (NIH), Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD)
Conditions Transgenderism, Reproductive Issues
Enrollment 80 participants
Start Date 2025-12-05
Primary Completion 2028-11-15 (estimated)
Study Completion 2028-11-30 (estimated)
Updated on ClinicalTrials.gov 2026-01-15